BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30670070)

  • 1. Prediction models for dementia and neuropathology in the oldest old: the Vantaa 85+ cohort study.
    Hall A; Pekkala T; Polvikoski T; van Gils M; Kivipelto M; Lötjönen J; Mattila J; Kero M; Myllykangas L; Mäkelä M; Oinas M; Paetau A; Soininen H; Tanskanen M; Solomon A
    Alzheimers Res Ther; 2019 Jan; 11(1):11. PubMed ID: 30670070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.
    Paradela RS; Justo AFO; Paes VR; Leite REP; Pasqualucci CA; Grinberg LT; Naslavsky MS; Zatz M; Nitrini R; Jacob-Filho W; Suemoto CK
    Acta Neuropathol Commun; 2023 Dec; 11(1):205. PubMed ID: 38115150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AD and non-AD mediators of the pathway between the APOE genotype and cognition.
    Nichols E; Brickman AM; Casaletto KB; Dams-O'Connor K; George KM; Kumar RG; Palta P; Rabin JS; Satizabal CL; Schneider J; Pa J; La Joie R
    Alzheimers Dement; 2023 Jun; 19(6):2508-2519. PubMed ID: 36516004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology.
    Pillai JA; Bena J; Tousi B; Rothenberg K; Keene CD; Leverenz JB
    Alzheimers Dement; 2024 Apr; 20(4):2564-2574. PubMed ID: 38353367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocortical β-amyloid area is associated with dementia and APOE in the oldest-old.
    Berlau DJ; Corrada MM; Robinson JL; Geser F; Arnold SE; Lee VM; Kawas CH; Trojanowski JQ
    Alzheimers Dement; 2013 Nov; 9(6):699-705. PubMed ID: 23474043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAIDE Dementia Risk Score, Alzheimer and cerebrovascular pathology: a population-based autopsy study.
    Hooshmand B; Polvikoski T; Kivipelto M; Tanskanen M; Myllykangas L; Mäkelä M; Oinas M; Paetau A; Solomon A
    J Intern Med; 2018 Jun; 283(6):597-603. PubMed ID: 29411449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary age-related tauopathy in a Finnish population-based study of the oldest old (Vantaa 85+).
    Savola S; Kaivola K; Raunio A; Kero M; Mäkelä M; Pärn K; Palta P; Tanskanen M; Tuimala J; Polvikoski T; Tienari PJ; Paetau A; Myllykangas L
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12788. PubMed ID: 34927275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study.
    Corrada MM; Paganini-Hill A; Berlau DJ; Kawas CH
    Alzheimers Dement; 2013 Jan; 9(1):12-8. PubMed ID: 23123227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based analysis of pathological correlates of dementia in the oldest old.
    Tanskanen M; Mäkelä M; Notkola IL; Myllykangas L; Rastas S; Oinas M; Lindsberg PJ; Polvikoski T; Tienari PJ; Paetau A
    Ann Clin Transl Neurol; 2017 Mar; 4(3):154-165. PubMed ID: 28275649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capillary amyloid-β protein deposition in a population-based study (Vantaa 85+).
    Mäkelä M; Paetau A; Polvikoski T; Myllykangas L; Tanskanen M
    J Alzheimers Dis; 2016; 49(1):149-57. PubMed ID: 26444758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOEε2 is associated with milder clinical and pathological Alzheimer disease.
    Serrano-Pozo A; Qian J; Monsell SE; Betensky RA; Hyman BT
    Ann Neurol; 2015 Jun; 77(6):917-29. PubMed ID: 25623662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
    Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BN; Scheltens P; Visser PJ; ; Verfaillie SC; Zwan MD; Adriaanse SM; Lammertsma AA; Barkhof F; Jagust WJ; Miller BL; Rosen HJ; Landau SM; Villemagne VL; Rowe CC; Lee DY; Na DL; Seo SW; Sarazin M; Roe CM; Sabri O; Barthel H; Koglin N; Hodges J; Leyton CE; Vandenberghe R; van Laere K; Drzezga A; Forster S; Grimmer T; Sánchez-Juan P; Carril JM; Mok V; Camus V; Klunk WE; Cohen AD; Meyer PT; Hellwig S; Newberg A; Frederiksen KS; Fleisher AS; Mintun MA; Wolk DA; Nordberg A; Rinne JO; Chételat G; Lleo A; Blesa R; Fortea J; Madsen K; Rodrigue KM; Brooks DJ
    JAMA; 2015 May; 313(19):1939-49. PubMed ID: 25988463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology.
    Mortimer JA; Snowdon DA; Markesbery WR
    Alzheimer Dis Assoc Disord; 2009; 23(2):152-7. PubMed ID: 19484916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.